Bartholdy, Savani http://orcid.org/0000-0002-4083-5809
Allen, Karina
Hodsoll, John
O’Daly, Owen G.
Campbell, Iain C.
Banaschewski, Tobias
Bokde, Arun L. W.
Bromberg, Uli
Büchel, Christian
Quinlan, Erin Burke
Conrod, Patricia J.
Desrivières, Sylvane
Flor, Herta
Frouin, Vincent
Gallinat, Jürgen
Garavan, Hugh
Heinz, Andreas
Ittermann, Bernd
Martinot, Jean-Luc
Artiges, Eric
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Paus, Tomáš
Poustka, Luise
Smolka, Michael N.
Mennigen, Eva
Walter, Henrik
Whelan, Robert
Schumann, Gunter
Schmidt, Ulrike
Funding for this research was provided by:
Sixth Framework Programme (LSHM-CT- 2007-037286 (IMAGEN))
Seventh Framework Programme (602450 (IMAGEMEND), 602805 (AGGRESSOTYPE), 603016 (MATRICS), 115300-2 (EU-AIMS))
Medical Research Council (93558 ("Developmental pathways into adolescent substance abuse"), MR/N000390/1 (c-VEDA))
VR
FORTE
Svenska Forskningsrådet Formas
National Institute for Health Research (Infrastructure grant for the Wellcome Trust/KCL Clinical Research Facility)
National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
Bundesministerium für Bildung und Forschung (01GS08152, 01EV0711, eMED SysAlc 01ZX1311A, Forschungsnetz AERIAL)
Deutsche Forschungsgemeinschaft (SM 80/7-1, SM 80/7-2, SFB 940/1)
Euranet-Neuron (AF12-NEUR0008-01 - WM2NA)
Agence Nationale de la Recherche (ANR-12-SAMA-0004)
Fondation de France
Fondation pour la Recherche Médicale
Mission Interministerielle de Lutte-contr-les-Drogues-et-les-Conduites-Addictives
Assistance Publique - Hôpitaux de Paris
INSERM, Paris Sud University
National Institutes of Health (Axon, Testosterone and Mental Health during Adolescence, RO1 MH085772-01A1, Consortium grant U54 EB020403)
Article History
Received: 9 August 2016
Accepted: 19 December 2016
First Online: 3 January 2017
Compliance with ethical standards
:
: The study procedures were approved by the local ethics committee at each respective site, and were conducted in accordance with the Declaration of Helsinki. Written informed consent from the parents and written assent from the children were obtained prior to participation.
: Dr. Banaschewski has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. Dr. Gallinat has received research funding from the German Federal Ministry of Education and Research, AstraZeneca, Eli Lilly, Janssen-Cilag, and Bristol-Myers Squibb; he has received speaking fees from AstraZeneca, Janssen-Cilag, and Bristol-Myers Squibb. Dr Barker has received honoraria from General Electric for teaching on scanner programming courses. The other authors report no biomedical financial interests or potential conflicts of interest.